Evaluation of Therapeutic Effect of Bandage Contact Lenses ( BCL) on Dry Eye Caused by Sjogren's Syndrome
NCT02147509 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64
Last updated 2014-07-22
Summary
The purpose of this study is to evaluate the therapeutic effect and safety of therapeutic bandage contact lenses treating dry eye caused by Sjögren's syndrome.
Conditions
- Sjögren's Syndrome Patients With Severe Dry Eye
Interventions
- DRUG
-
0.02% Fm, SH
Sjogren's Syndrome patients with severe dry eye
- DRUG
-
0.02% Fm, SH, 0.05% CsA
Sjogren's Syndrome patients with severe dry eye
- OTHER
-
0.02% Fm, SH, tBCL
Sjogren's Syndrome patients with severe dry eye
- DRUG
-
0.02% Fm, SH, AS
Sjogren's Syndrome patients with severe dry eye
Sponsors & Collaborators
-
Jinyang Li
lead OTHER
Principal Investigators
-
Jinyang Li, MD,PhD · Eye Hospital, Wenzhou Medical College, China
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-03-31
- Primary Completion
- 2014-04-30
- Completion
- 2014-04-30
Countries
- China
Study Locations
More Related Trials
-
A Study to Evaluate the Efficacy and Safety of Treatment With CsA-PG Ophthalmic Gel in Dry Eye Patients
NCT06942793 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Evaluation of FID 114657 in Sjogren's Syndrome Subjects
NCT01079871 ·Status: COMPLETED ·Phase: NA
-
A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren Syndrome
NCT02011776 ·Status: COMPLETED
-
Study on Prevention and Treatment of Dry Eye in Patients Using Glaucoma Drops
NCT03515187 ·Status: UNKNOWN ·Phase: PHASE3
-
YM-101 Eye Drops in the Treatment of Dry Eye Syndrome
NCT06792903 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
MSCohi-O Lenses for Ocular Involvement in Sjögren's Syndrome
NCT07185139 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Use of 5.0% Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease in Contact Lens Wearers
NCT03431272 ·Status: WITHDRAWN ·Phase: PHASE4
-
Evaluate the Efficacy and Safety of LO2A Eye Drops for Symptomatic Improvement of Dry Eye in Patients With Sjögren's Syndrome
NCT03319420 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of 0.05% Cyclosporine A Eye Drops Combined With Absorbable Tear Duct Plugs in the Treatment of Dry Eye in Sjögren's Syndrom
NCT07171710 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Autologous Serum Eye Drops in Dry Eye Syndrome
NCT07295691 ·Status: RECRUITING ·Phase: NA
-
Levocarnitine for Dry Eye in Sjogren's Syndrome
NCT03953703 ·Status: COMPLETED ·Phase: PHASE2
-
Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01189032 ·Status: COMPLETED ·Phase: PHASE2
-
A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes
NCT01692145 ·Status: COMPLETED ·Phase: PHASE2
-
Autologous Serum Efficacy Study in Patients With Severe Dry Eye
NCT00779987 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Corneal Neurosensory Abnormalities in Patients With Sjögren's Dry Eye
NCT06411132 ·Status: TERMINATED
-
Safety, Tolerability and Systemic Pharmacokinetics of AGN-232411 in Healthy Participants and Participants With Dry Eye
NCT02420730 ·Status: COMPLETED ·Phase: PHASE1
-
Laser Acupuncture on Dry Eye and Sjögren's Syndrome-related Dry Eye Symptoms (LADESJS)
NCT06780293 ·Status: RECRUITING ·Phase: PHASE2
-
Safety, Efficacy, Tolerability and Pharmacokinetics of AGN-223575 Ophthalmic Suspension in Patients With Dry Eye Disease
NCT02435914 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of RX-10045 in the Treatment of Dry Eye Disease
NCT01675570 ·Status: COMPLETED ·Phase: PHASE2
-
DNase Treatment for Dry Eyes
NCT02193490 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of XG-104 for the Treatment of Dry Eye
NCT02235259 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Study of the Safety and Effectiveness of the TearCare System for the Signs and Symptoms of Dry Eye Disease
NCT03502447 ·Status: TERMINATED ·Phase: NA
-
Sjögren's Syndrome Is Associated With Meibomian Gland Dysfunction
NCT03434106 ·Status: UNKNOWN ·Phase: NA
-
BroadBand Light for the Treatment of Dry Eye Disease
NCT06174064 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Long-term Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
NCT02503163 ·Status: COMPLETED ·Phase: PHASE3